Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Dominik Horn, Jochen Hess, Kolja Freier, Jürgen Hoffmann & Christian Freudlsperger. (2015) Targeting EGFR-PI3K-AKT-mTOR signaling enhances radiosensitivity in head and neck squamous cell carcinoma. Expert Opinion on Therapeutic Targets 19:6, pages 795-805.
Read now
Read now
Christian Freudlsperger, Jeffrey R Burnett, Jay A Friedman, Vishnu R Kannabiran, Zhong Chen & Carter Van Waes. (2011) EGFR–PI3K–AKT–mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy. Expert Opinion on Therapeutic Targets 15:1, pages 63-74.
Read now
Read now
Articles from other publishers (36)
Yuhan Yang, Liting Xiong, Mengyuan Li, Ping Jiang, Junjie Wang & Chunxiao Li. (2023) Advances in radiotherapy and immunity in hepatocellular carcinoma. Journal of Translational Medicine 21:1.
Crossref
Crossref
Eri Sasabe, Ayumi Tomomura, Hangyu Liu, Shinya Sento, Naoya Kitamura & Tetsuya Yamamoto. (2021) Epidermal growth factor/epidermal growth factor receptor signaling blockage inhibits tumor cell‐derived exosome uptake by oral squamous cell carcinoma through macropinocytosis. Cancer Science 113:2, pages 609-621.
Crossref
Crossref
Stanislav S. Piletsky, Elena Piletska, Marta Poblocka, Salvador Macip, Donald J.L. Jones, Marta Braga, Thong H. Cao, Rajinder Singh, Alan C. Spivey, Eric O. Aboagye & Sergey A. Piletsky. (2021) Snapshot imprinting: rapid identification of cancer cell surface proteins and epitopes using molecularly imprinted polymers. Nano Today 41, pages 101304.
Crossref
Crossref
Radhika R. Gudi, Harinarayanan Janakiraman, Philip H. Howe, Viswanathan Palanisamy & Chenthamarakshan Vasu. (2021) Loss of CPAP causes sustained EGFR signaling and epithelial-mesenchymal transition in oral cancer. Oncotarget 12:8, pages 807-822.
Crossref
Crossref
Yu-Jung Chang, Kuan-Wei Chen & Linyi Chen. (2020) Mitochondrial ROS1 Increases Mitochondrial Fission and Respiration in Oral Squamous Cancer Carcinoma. Cancers 12:10, pages 2845.
Crossref
Crossref
Linah A. Shahoumi, Hesam Khodadadi, Husam Bensreti, Babak Baban & W. Andrew Yeudall. (2020) EPS8 phosphorylation by Src modulates its oncogenic functions. British Journal of Cancer 123:7, pages 1078-1088.
Crossref
Crossref
Phillip J. Hsu, Kenneth Yan, Hailing Shi, Evgeny Izumchenko & Nishant Agrawal. (2020) Molecular biology of oral cavity squamous cell carcinoma. Oral Oncology 102, pages 104552.
Crossref
Crossref
Po-Ku Chen, Chun-Hung Hua, Hui-Ting Hsu, Tzer-Min Kuo, Chia-Min Chung, Chi-Pin Lee, Ming-Hsui Tsai, Kun-Tu Yeh & Ying-Chin Ko. (2019) ALPK1 Expression Is Associated with Lymph Node Metastasis and Tumor Growth in Oral Squamous Cell Carcinoma Patients. The American Journal of Pathology 189:1, pages 190-199.
Crossref
Crossref
Amritha Suresh, Ram Bhupal Reddy, Bonney Lee James & Moni Abraham Kuriakose. 2017. Contemporary Oral Oncology. Contemporary Oral Oncology
291
316
.
Santosh Katiyar. (2016) Emerging Phytochemicals for the Prevention and Treatment of Head and Neck Cancer. Molecules 21:12, pages 1610.
Crossref
Crossref
Hiroko Kitahara, Mariko Hirai, Koroku Kato, George Bou-Gharios, Hiroyuki Nakamura & Shuichi Kawashiri. (2016) Eribulin sensitizes oral squamous cell carcinoma cells to cetuximab via induction of mesenchymal-to-epithelial transition. Oncology Reports.
Crossref
Crossref
Arya Sobhakumari, Kevin P. Orcutt, Laurie Love-Homan, Christopher E. Kowalski, Arlene D. Parsons, C. Michael Knudson & Andrean L. Simons. (2016) 2-Deoxy-d-glucose Suppresses the In Vivo Antitumor Efficacy of Erlotinib in Head and Neck Squamous Cell Carcinoma Cells. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 24:1, pages 55-64.
Crossref
Crossref
IYO KIMURA, HIROKO KITAHARA, KAZUHIRO OOI, KOROKU KATO, NATUYO NOGUCHI, KUNIO YOSHIZAWA, HIROYUKI NAKAMURA & SHUICHI KAWASHIRI. (2016) Loss of epidermal growth factor receptor expression in oral squamous cell carcinoma is associated with invasiveness and epithelial-mesenchymal transition. Oncology Letters 11:1, pages 201-207.
Crossref
Crossref
Juan Madoz-G?rpide, Sandra Zazo, Cristina Chamizo, Victoria Casado, Cristina Caram?s, Eduardo Gav?n, Ion Crist?bal, Jes?s Garc?a-Foncillas & Federico Rojo. (2015) Activation of MET pathway predicts poor outcome to cetuximab in patients with recurrent or metastatic head and neck cancer. Journal of Translational Medicine 13:1.
Crossref
Crossref
Christian Freudlsperger, Dominik Horn, Sebastian Weißfuß, Wilko Weichert, Klaus-Josef Weber, Daniel Saure, Sarika Sharma, Gerhard Dyckhoff, Niels Grabe, Peter Plinkert, Jürgen Hoffmann, Kolja Freier & Jochen Hess. (2015) Phosphorylation of AKT(Ser473) serves as an independent prognostic marker for radiosensitivity in advanced head and neck squamous cell carcinoma. International Journal of Cancer 136:12, pages 2775-2785.
Crossref
Crossref
Adam T. Koch, Laurie Love-Homan, Madelyn Espinosa-Cotton, Aditya Stanam & Andrean L. Simons. (2015) MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells. Cancer Research 75:8, pages 1657-1667.
Crossref
Crossref
Bhavna Chulliparampil Mohan. (2015) Unraveling the role of epidermal growth factor receptor in oral lesions: Key to non surgical treatment modes. World Journal of Stomatology 4:1, pages 22.
Crossref
Crossref
Keith M. Giles, Felicity C. Kalinowski, Patrick A. Candy, Michael R. Epis, Priscilla M. Zhang, Andrew D. Redfern, Lisa M. Stuart, Gregory J. Goodall & Peter J. Leedman. (2013) Axl Mediates Acquired Resistance of Head and Neck Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Erlotinib. Molecular Cancer Therapeutics 12:11, pages 2541-2558.
Crossref
Crossref
Sufi M. Thomas, Bichismita Sahu, Srinivas Rapireddy, Raman Bahal, Sarah E. Wheeler, Eva M. Procopio, Joseph Kim, Sonali C. Joyce, Sarah Contrucci, Yun Wang, Simion I. Chiosea, Kira L. Lathrop, Simon Watkins, Jennifer R. Grandis, Bruce A. Armitage & Danith H. Ly. (2012) Antitumor Effects of EGFR Antisense Guanidine-Based Peptide Nucleic Acids in Cancer Models. ACS Chemical Biology 8:2, pages 345-352.
Crossref
Crossref
Adam Jedlinski, Anna Ansell, Ann‐Charlotte Johansson & Karin Roberg. (2012) EGFR status and EGFR ligand expression influence the treatment response of head and neck cancer cell lines. Journal of Oral Pathology & Medicine 42:1, pages 26-36.
Crossref
Crossref
Felicity C. Kalinowski, Keith M. Giles, Patrick A. Candy, Alishum Ali, Clarissa Ganda, Michael R. Epis, Rebecca J. Webster & Peter J. Leedman. (2012) Regulation of Epidermal Growth Factor Receptor Signaling and Erlotinib Sensitivity in Head and Neck Cancer Cells by miR-7. PLoS ONE 7:10, pages e47067.
Crossref
Crossref
M. Ingargiola, C. Dittfeld, R. Runge, M. Zenker, J.-M. Heldt, J. Steinbach, N. Cordes, M. Baumann, J. Kotzerke & L. A. Kunz-Schughart. (2012) Flow cytometric cell-based assay to preselect antibody constructs for radionuclide conjugation. Cytometry Part A 81A:10, pages 865-873.
Crossref
Crossref
Dirk Strumberg, Beate Schultheis, M. E. Scheulen, R. A. Hilger, J. Krauss, N. Marschner, F. Lordick, F. Bach, D. Reuter, L. Edler & K. Mross. (2010) Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer. Investigational New Drugs 30:3, pages 1138-1143.
Crossref
Crossref
Benson G. Ongarora, Krystal R. Fontenot, Xiaoke Hu, Inder Sehgal, Seetharama D. Satyanarayana-Jois & M. Graça H. Vicente. (2012) Phthalocyanine–Peptide Conjugates for Epidermal Growth Factor Receptor Targeting. Journal of Medicinal Chemistry 55:8, pages 3725-3738.
Crossref
Crossref
Jason D. Howard, Bo Lu & Christine H. Chung. (2012) Therapeutic targets in head and neck squamous cell carcinoma: Identification, evaluation, and clinical translation. Oral Oncology 48:1, pages 10-17.
Crossref
Crossref
Dennis Pfaff, Maria Philippova, Emmanouil Kyriakakis, Kseniya Maslova, Katharina Rupp, Stanislaw A Buechner, Giandomenica Iezzi, Giulio C Spagnoli, Paul Erne & Therese J Resink. (2011) Paradoxical effects of T‐cadherin on squamous cell carcinoma: up‐ and down‐regulation increase xenograft growth by distinct mechanisms. The Journal of Pathology 225:4, pages 512-524.
Crossref
Crossref
Susy M. E. Scholl, Gemma Kenter, Christian Kurzeder & Philippe Beuzeboc. (2011) Pathway Profiling and Rational Trial Design for Studies in Advanced Stage Cervical Carcinoma: A Review and a Perspective. ISRN Oncology 2011, pages 1-13.
Crossref
Crossref
Jennifer L. Hunt. (2011) An Update on Molecular Diagnostics of Squamous and Salivary Gland Tumors of the Head and Neck. Archives of Pathology & Laboratory Medicine 135:5, pages 602-609.
Crossref
Crossref
Sebastian Schmeier, Ulf Schaefer, Cameron R. MacPherson & Vladimir B. Bajic. (2011) dPORE-miRNA: Polymorphic Regulation of MicroRNA Genes. PLoS ONE 6:2, pages e16657.
Crossref
Crossref
Mitchell J. Frederick, Amy J. VanMeter, Mayur A. Gadhikar, Ying C. Henderson, Hui Yao, Curtis C. Pickering, Michelle D. Williams, Adel K. El-Naggar, Vlad Sandulache, Emily Tarco, Jeffrey N. Myers, Gary L. Clayman, Lance A. Liotta, Emanuel F. PetricoinIIIIII, Valerie S. Calvert, Valentina Fodale, Jing Wang & Randal S. Weber. (2011) Phosphoproteomic Analysis of Signaling Pathways in Head and Neck Squamous Cell Carcinoma Patient Samples. The American Journal of Pathology 178:2, pages 548-571.
Crossref
Crossref
Jennifer L. Hunt. 2011. Diagnostic Immunohistochemistry. Diagnostic Immunohistochemistry
256
290
.
Rebecca J. Leeman-Neill, Quan Cai, Sonali C. Joyce, Sufi M. Thomas, Neil E. Bhola, Daniel B. Neill, Jack L. Arbiser & Jennifer R. Grandis. (2010) Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor Inhibitors. Clinical Cancer Research 16:9, pages 2571-2579.
Crossref
Crossref
Federico Rojo, Elías Gracias, Nadia Villena, Teresa Cruz, Josep Maria Corominas, Irene Corradino, Mercedes Cedeño, Clara Campas, Marta Osorio, Normando Iznaga, Beatriz Bellosillo, Ana Rovira, Silvia Marsoni, Pere Gascon, Sergio Serrano, Cristiana Sessa, Tania Crombet & Joan Albanell. (2010) Pharmacodynamic Trial of Nimotuzumab in Unresectable Squamous Cell Carcinoma of the Head and Neck: A SENDO Foundation Study. Clinical Cancer Research 16:8, pages 2474-2482.
Crossref
Crossref
Frederick Wang, Pattatheyil Arun, Jay Friedman, Zhong Chen & Carter Van Waes. (2009) Current and potential inflammation targeted therapies in head and neck cancer. Current Opinion in Pharmacology 9:4, pages 389-395.
Crossref
Crossref
Paul Dent, David T. Curiel, Paul B. Fisher & Steven Grant. (2009) Synergistic combinations of signaling pathway inhibitors: Mechanisms for improved cancer therapy. Drug Resistance Updates 12:3, pages 65-73.
Crossref
Crossref
Remilio A. L. Schoop, Mathieu H. M. Noteborn & Robert J. Baatenburg de Jong. (2009) A mouse model for oral squamous cell carcinoma. Journal of Molecular Histology 40:3, pages 177-181.
Crossref
Crossref